EUVIMEDEUVIMED entdecken
Open Access

Increased levels of nectin-4 as a serological marker for pre-eclampsia

Hikari Yoshizawa, Haruki Nishizawa, Mayuko Ito, Akiko Ohwaki, Yoshiko Sakabe, Takao Sekiya, Takuma Fujii, Hiroki Kurahashi

Fujita Medical Journal · 2023-08 · 9 (3) · 200-205

DOI: 10.20407/fmj.2022-027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fujita Medical Journal, 2023-08. Verfasst von Hikari Yoshizawa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Nectin-4 is a cell adhesion molecule with vital functions at adherens and tight junctions. Cumulative evidence now indicates that the NECTIN4 gene is overexpressed in a variety of cancers, and that the nectin-4 protein is both a disease marker and therapeutic target in a subset of these cancers. We previously demonstrated that NECTIN4 is overexpressed in placenta during pre-eclamptic pregnancy, which is one of the most serious obstetric disorders.

Methods

Nectin-4 protein levels were measured in maternal sera from pregnant women with pre-eclampsia and its related disorder, unexplained fetal growth retardation.

Results

Maternal serum concentrations of nectin-4 were significantly elevated in pre-eclamptic women compared with those with an uncomplicated normotensive pregnancy. However, no increase was observed in pregnancies with unexplained fetal growth retardation. Serum nectin-4 levels were higher in cases with early-onset pre-eclampsia that generally showed more severe clinical symptoms, but levels were not correlated to other clinical indicators of disease severity.

Conclusions

Nectin-4 is a potential new diagnostic and predictive biomarker for severe pre-eclampsia.

Schlagwörter

Stichwörter der Autor:innen

NECTIN4PlacentaPre-eclampsia

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
  • Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Aichi, Japan.

Zitieren

APA

Yoshizawa, H., Nishizawa, H., Ito, M., Ohwaki, A., Sakabe, Y., Sekiya, T., Fujii, T., & Kurahashi, H. (2023). Increased levels of nectin-4 as a serological marker for pre-eclampsia. Fujita Medical Journal, 9(3), 200-205. https://doi.org/10.20407/fmj.2022-027

Vancouver

Yoshizawa H, Nishizawa H, Ito M, Ohwaki A, Sakabe Y, Sekiya T, et al. Increased levels of nectin-4 as a serological marker for pre-eclampsia. Fujita Medical Journal. 2023;9(3):200-205. doi:10.20407/fmj.2022-027

BibTeX
@article{Yoshizawa2023,
  author = {Yoshizawa, Hikari and Nishizawa, Haruki and Ito, Mayuko and Ohwaki, Akiko and Sakabe, Yoshiko and Sekiya, Takao and Fujii, Takuma and Kurahashi, Hiroki},
  title = {Increased levels of nectin-4 as a serological marker for pre-eclampsia},
  journal = {Fujita Medical Journal},
  year = {2023},
  volume = {9},
  number = {3},
  pages = {200--205},
  doi = {10.20407/fmj.2022-027}
}
Kostenlos starten →